Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan
· Delayed Price · Currency is TWD 35.50
+5.10 (16.78%)
Apr 29, 2026, 1:59 PM CST
Diamond Biotechnology Revenue
Diamond Biotechnology had revenue of 317.60M TWD in the half year ending June 30, 2025, with 7.19% growth. This brings the company's revenue in the last twelve months to 698.11M, down -1.33% year-over-year. In the year 2024, Diamond Biotechnology had annual revenue of 768.25M with 24.70% growth.
Revenue (ttm)
698.11M
Revenue Growth
-1.33%
P/S Ratio
2.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.43B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| AViTA | 936.39M |
| Wiltrom | 311.77M |
| Cowealth Medical Holding | 2.96B |
| Bioptik Technology Incorporation | 837.19M |
| PlexBio | 127.10M |
| S&S Healthcare Holding | 204.21M |
| Taiwan Biomaterial | 220.40M |